Journal
JOURNAL OF RHEUMATOLOGY
Volume 37, Issue 4, Pages 766-775Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.090663
Keywords
DISEASE ACTIVITY; HIGH MOBILITY GROUP BOX CHROMOSOMAL PROTEIN 1; INTERLEUKIN 6; SYSTEMIC LUPUS ERYTHEMATOSUS; TUMOR NECROSIS FACTOR-alpha
Categories
Funding
- Central South University Graduate School Research Foundation
- Science and Technology Project of Hunan Province [06FJ3150]
Ask authors/readers for more resources
Objective. To compare the expression of high mobility group box chromosomal protein 1 (HMGB1) and the modulating effects on its downstream cytokines in patients with systemic lupus erythematosus (SLE) and healthy controls. Methods. HMGB1 concentrations in serum from SLE patients and controls were measured by immunoblot analysis. HMGB1 messenger RNA (mRNA) expression in peripheral blood mononuclear cells (PBMC) was detected by real-time reverse transcription polymerase chain reaction. Immunofluorescence assay was employed to examine the translocation of HMGB1 in monocytes after endotoxin stimulation. Release of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) by PBMC after rHMGB1 stimulation was also measured. Results. Serum HMGB1 levels and HMGB1 mRNA expressions in PBMC were elevated in SLE patients compared with controls. A positive correlation was demonstrated between HMGB1 concentrations and SLE Disease Activity Index. There was an inverse correlation between HMGB1 levels and C4 and C3 concentrations in SLE patients. HMGB1 concentrations were higher in patients with vasculitis and myositis. Lipopolysaccharide stimulated a temporarily elevated release of HMGB1 in SLE patients compared with controls. The pattern and localization of HMGB1 staining in monocytes were similar in both groups. After stimulation with rHMGB1, TNF-alpha level decreased but IL-6 level increased in SLE patients compared with controls. Conclusion. Our findings suggest that increased serum levels of HMGB1 in SLE may be associated with lupus disease activity. The altered production of TNF-alpha and IL-6 in response to rHMGB1 stimulation may participate in the disruption of cytokine homeostasis in SLE. (First Release Feb 1 2010; J Rheumatol 2010;37:766-75; doi: 10.3899/jrheum.090663)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available